SAN DIEGO, March 31, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a conference call to discuss the Company's decision to fast-track the development of its "thin-strut" fully bioresorbable scaffold family, Fantom™. Robert Stockman, the Company's Chairman and Chief Executive Officer, will host the call.
Help employers find you! Check out all the jobs and post your resume.